C57BL/6JCya-Ttnem1/Cya
Common Name
Ttn-KO
Product ID
S-KO-05587
Backgroud
C57BL/6JCya
Strain ID
KOCMP-22138-Ttn-B6J-VA
When using this mouse strain in a publication, please cite “Ttn-KO Mouse (Catalog S-KO-05587) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Ttn-KO
Strain ID
KOCMP-22138-Ttn-B6J-VA
Gene Name
Product ID
S-KO-05587
Gene Alias
1100001C23Rik, 2310036G12Rik, 2310057K23Rik, 2310074I15Rik, D330041I19Rik, D830007G01Rik, L56, mdm, shru
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr 2
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000099981
NCBI RefSeq
NM_001385708
Target Region
Exon 4~6
Size of Effective Region
~2.0 kb
Overview of Gene Research
Ttn, encoding the giant sarcomere protein titin, is a major determinant of cardiomyocyte stiffness and contributes to cardiac strain sensing. Titin-based forces are crucial in regulating myocardial function, such as cardiac filling and output. It forms the myofibrillar backbone for the contractile machinery components, playing a vital role in muscle disorders and cardiomyopathies [1,2].
Mutations in the TTN gene are the most common causes of dilated cardiomyopathy (DCM). TTN truncating variants (tTTN) reduce normal TTN protein levels, produce truncated proteins, and impair sarcomere content and function. In a study of 1,041 patients with sporadic DCM, tTTN were detected in 120 (11.5%) patients. DCM patients with tTTN had a lower left ventricular ejection fraction and a lower frequency of the left bundle branch block, but tTTN were not associated with the composite primary endpoint of cardiac death and heart transplantation during the follow-up period [3]. TTN truncating mutations are a common cause of dilated cardiomyopathy, occurring in approximately 25% of familial cases of idiopathic DCM and in 18% of sporadic cases [4].
In conclusion, Ttn is essential for myocardial function, especially in maintaining cardiomyocyte stiffness and contributing to cardiac strain sensing. Studies on TTN mutations, especially truncating variants, have revealed their significant association with dilated cardiomyopathy, highlighting the importance of Ttn in understanding the pathophysiology of this cardiac disorder.
References:
1. Loescher, Christine M, Hobbach, Anastasia J, Linke, Wolfgang A. . Titin (TTN): from molecule to modifications, mechanics, and medical significance. In Cardiovascular research, 118, 2903-2918. doi:10.1093/cvr/cvab328. https://pubmed.ncbi.nlm.nih.gov/34662387/
2. Jolfayi, Amir Ghaffari, Kohansal, Erfan, Ghasemi, Serwa, Maleki, Majid, Kalayinia, Samira. 2024. Exploring TTN variants as genetic insights into cardiomyopathy pathogenesis and potential emerging clues to molecular mechanisms in cardiomyopathies. In Scientific reports, 14, 5313. doi:10.1038/s41598-024-56154-7. https://pubmed.ncbi.nlm.nih.gov/38438525/
3. Xiao, Lei, Li, Chenze, Sun, Yang, Marian, Ali J, Wang, Dao Wen. 2021. Clinical Significance of Variants in the TTN Gene in a Large Cohort of Patients With Sporadic Dilated Cardiomyopathy. In Frontiers in cardiovascular medicine, 8, 657689. doi:10.3389/fcvm.2021.657689. https://pubmed.ncbi.nlm.nih.gov/33996946/
4. Herman, Daniel S, Lam, Lien, Taylor, Matthew R G, Seidman, J G, Seidman, Christine E. . Truncations of titin causing dilated cardiomyopathy. In The New England journal of medicine, 366, 619-28. doi:10.1056/NEJMoa1110186. https://pubmed.ncbi.nlm.nih.gov/22335739/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
